Xu, Weimin
Ren, Zixuan
Yang, Li
Cui, Yue
Funding for this research was provided by:
National Natural Science Foundation of China (82130021, 52072007)
High Quality Clinical Research Project of Peking University First Hospital (2022CR83, 2022CX15)
Beijing Young Scientist Program (BJJWZYJH01201910001006)
CAMS Innovation Fund for Medical Sciences (2019-I2M-5-046, 2020-JKCS-009)
PKU-Baidu Fund (2020BD026, 2020BD044)
Capital's Funds for Health Improvement and Research (CFH2022-1-4071)
State Key Laboratory of Vascular Homeostasis and Remodeling of Peking University
National Key R&D Program of China (2022YFB3204400)
Article History
Received: 21 December 2024
Accepted: 10 March 2025
First Online: 30 April 2025
Declarations
:
: The clinical trial protocols were approved by the Research Ethics Committee of Peking University First Hospital (approval number: 2024–164).
: The authors declare no competing interests.